CAR T-Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Allogeneic, Autologous), By Application (Hospitals, Cancer Research Centers, Others), Regional Insights and Forecast to 2035
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global CAR T-Cell Therapy Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 CAR T-Cell Therapy Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 CAR T-Cell Therapy Business Mode and Production Process
2.3.1 CAR T-Cell Therapy Business Mode Analysis
2.3.2 Production Process Analysis
2.4 CAR T-Cell Therapy Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of CAR T-Cell Therapy
2.4.2 Raw Material Cost of CAR T-Cell Therapy
2.4.3 Labor Cost of CAR T-Cell Therapy
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global CAR T-Cell Therapy Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global CAR T-Cell Therapy Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global CAR T-Cell Therapy Price by Manufacturer (2021-2026)
4.4 CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of CAR T-Cell Therapy, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of CAR T-Cell Therapy, Product Offered and Application
4.7 CAR T-Cell Therapy Market Competitive Situation and Trends
4.7.1 CAR T-Cell Therapy Market Concentration Rate
4.7.2 Global Top 3 and Top 6 CAR T-Cell Therapy Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global CAR T-Cell Therapy Market Historical Development by Geographic Region (2021-2026)
5.1 Global CAR T-Cell Therapy Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global CAR T-Cell Therapy Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America CAR T-Cell Therapy Market Status by Country (2021-2026)
5.3.1 North America CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.3.2 North America CAR T-Cell Therapy Revenue by Country (2021-2026)
5.3.3 United States CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe CAR T-Cell Therapy Market Status by Country (2021-2026)
5.4.1 Europe CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.4.2 Europe CAR T-Cell Therapy Revenue by Country (2021-2026)
5.4.3 Germany CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific CAR T-Cell Therapy Market Status by Country (2021-2026)
5.5.1 Asia Pacific CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific CAR T-Cell Therapy Revenue by Country (2021-2026)
5.5.3 China CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America CAR T-Cell Therapy Market Status by Country (2021-2026)
5.6.1 Latin America CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.6.2 Latin America CAR T-Cell Therapy Revenue by Country (2021-2026)
5.6.3 Mexico CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa CAR T-Cell Therapy Market Status by Country (2021-2026)
5.7.1 Middle East and Africa CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa CAR T-Cell Therapy Revenue by Country (2021-2026)
5.7.3 GCC CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
6 Global CAR T-Cell Therapy Market Historical Development by Product Type (2021-2026)
6.1 CAR T-Cell Therapy Definition by Type
6.2 Global CAR T-Cell Therapy Historical Sales Volume by Product Type (2021-2026)
6.3 Global CAR T-Cell Therapy Historical Revenue by Product Type (2021-2026)
6.4 Global CAR T-Cell Therapy Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Allogeneic (2021-2026)
6.5.2 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Autologous (2021-2026)
7 Global CAR T-Cell Therapy Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global CAR T-Cell Therapy Historical Sales Volume by End User (2021-2026)
7.3 Global CAR T-Cell Therapy Historical Revenue by End User (2021-2026)
7.4 Global CAR T-Cell Therapy Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Cancer Research Centers (2021-2026)
7.5.3 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 Cellectis (France)
8.1.1 Cellectis (France) Corporation Information
8.1.2 Cellectis (France) - CAR T-Cell Therapy Product Portfolio and Specification
8.1.3 Cellectis (France) Performance Analysis (2021-2026)
8.1.4 Cellectis (France) Business and Markets Served
8.1.5 Cellectis (France) Recent Developments
8.2 CARsgen Therapeutics (China)
8.2.1 CARsgen Therapeutics (China) Corporation Information
8.2.2 CARsgen Therapeutics (China) - CAR T-Cell Therapy Product Portfolio and Specification
8.2.3 CARsgen Therapeutics (China) Performance Analysis (2021-2026)
8.2.4 CARsgen Therapeutics (China) Business and Markets Served
8.2.5 CARsgen Therapeutics (China) Recent Developments
8.3 Autolus Therapeutics PLC (UK)
8.3.1 Autolus Therapeutics PLC (UK) Corporation Information
8.3.2 Autolus Therapeutics PLC (UK) - CAR T-Cell Therapy Product Portfolio and Specification
8.3.3 Autolus Therapeutics PLC (UK) Performance Analysis (2021-2026)
8.3.4 Autolus Therapeutics PLC (UK) Business and Markets Served
8.3.5 Autolus Therapeutics PLC (UK) Recent Developments
8.4 Sorrento Therapeutics (US)
8.4.1 Sorrento Therapeutics (US) Corporation Information
8.4.2 Sorrento Therapeutics (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.4.3 Sorrento Therapeutics (US) Performance Analysis (2021-2026)
8.4.4 Sorrento Therapeutics (US) Business and Markets Served
8.4.5 Sorrento Therapeutics (US) Recent Developments
8.5 Mustang Bio (US)
8.5.1 Mustang Bio (US) Corporation Information
8.5.2 Mustang Bio (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.5.3 Mustang Bio (US) Performance Analysis (2021-2026)
8.5.4 Mustang Bio (US) Business and Markets Served
8.5.5 Mustang Bio (US) Recent Developments
8.6 Novartis AG (Switzerland)
8.6.1 Novartis AG (Switzerland) Corporation Information
8.6.2 Novartis AG (Switzerland) - CAR T-Cell Therapy Product Portfolio and Specification
8.6.3 Novartis AG (Switzerland) Performance Analysis (2021-2026)
8.6.4 Novartis AG (Switzerland) Business and Markets Served
8.6.5 Novartis AG (Switzerland) Recent Developments
8.7 Kite Pharma (US)
8.7.1 Kite Pharma (US) Corporation Information
8.7.2 Kite Pharma (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.7.3 Kite Pharma (US) Performance Analysis (2021-2026)
8.7.4 Kite Pharma (US) Business and Markets Served
8.7.5 Kite Pharma (US) Recent Developments
8.8 Legend Biotech (US)
8.8.1 Legend Biotech (US) Corporation Information
8.8.2 Legend Biotech (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.8.3 Legend Biotech (US) Performance Analysis (2021-2026)
8.8.4 Legend Biotech (US) Business and Markets Served
8.8.5 Legend Biotech (US) Recent Developments
8.9 Juno Therapeutics (US)
8.9.1 Juno Therapeutics (US) Corporation Information
8.9.2 Juno Therapeutics (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.9.3 Juno Therapeutics (US) Performance Analysis (2021-2026)
8.9.4 Juno Therapeutics (US) Business and Markets Served
8.9.5 Juno Therapeutics (US) Recent Developments
8.10 Pfizer, Inc. (US)
8.10.1 Pfizer, Inc. (US) Corporation Information
8.10.2 Pfizer, Inc. (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.10.3 Pfizer, Inc. (US) Performance Analysis (2021-2026)
8.10.4 Pfizer, Inc. (US) Business and Markets Served
8.10.5 Pfizer, Inc. (US) Recent Developments
9 Global CAR T-Cell Therapy Market Forecast by Product Type and End User (2026-2034)
9.1 Global CAR T-Cell Therapy Market Forecast by Product Type (2026-2034)
9.1.1 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Allogeneic (2026-2034)
9.1.2 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Autologous (2026-2034)
9.2 Global CAR T-Cell Therapy Market Forecast by End User (2026-2034)
9.2.1 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Cancer Research Centers (2026-2034)
9.2.3 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
10 Global CAR T-Cell Therapy Market Forecast by Geographic Region (2026-2034)
10.1 Global CAR T-Cell Therapy Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global CAR T-Cell Therapy Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 CAR T-Cell Therapy Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 CAR T-Cell Therapy Business Mode and Production Process
2.3.1 CAR T-Cell Therapy Business Mode Analysis
2.3.2 Production Process Analysis
2.4 CAR T-Cell Therapy Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of CAR T-Cell Therapy
2.4.2 Raw Material Cost of CAR T-Cell Therapy
2.4.3 Labor Cost of CAR T-Cell Therapy
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global CAR T-Cell Therapy Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global CAR T-Cell Therapy Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global CAR T-Cell Therapy Price by Manufacturer (2021-2026)
4.4 CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of CAR T-Cell Therapy, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of CAR T-Cell Therapy, Product Offered and Application
4.7 CAR T-Cell Therapy Market Competitive Situation and Trends
4.7.1 CAR T-Cell Therapy Market Concentration Rate
4.7.2 Global Top 3 and Top 6 CAR T-Cell Therapy Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global CAR T-Cell Therapy Market Historical Development by Geographic Region (2021-2026)
5.1 Global CAR T-Cell Therapy Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global CAR T-Cell Therapy Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America CAR T-Cell Therapy Market Status by Country (2021-2026)
5.3.1 North America CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.3.2 North America CAR T-Cell Therapy Revenue by Country (2021-2026)
5.3.3 United States CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe CAR T-Cell Therapy Market Status by Country (2021-2026)
5.4.1 Europe CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.4.2 Europe CAR T-Cell Therapy Revenue by Country (2021-2026)
5.4.3 Germany CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific CAR T-Cell Therapy Market Status by Country (2021-2026)
5.5.1 Asia Pacific CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific CAR T-Cell Therapy Revenue by Country (2021-2026)
5.5.3 China CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America CAR T-Cell Therapy Market Status by Country (2021-2026)
5.6.1 Latin America CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.6.2 Latin America CAR T-Cell Therapy Revenue by Country (2021-2026)
5.6.3 Mexico CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa CAR T-Cell Therapy Market Status by Country (2021-2026)
5.7.1 Middle East and Africa CAR T-Cell Therapy Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa CAR T-Cell Therapy Revenue by Country (2021-2026)
5.7.3 GCC CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa CAR T-Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
6 Global CAR T-Cell Therapy Market Historical Development by Product Type (2021-2026)
6.1 CAR T-Cell Therapy Definition by Type
6.2 Global CAR T-Cell Therapy Historical Sales Volume by Product Type (2021-2026)
6.3 Global CAR T-Cell Therapy Historical Revenue by Product Type (2021-2026)
6.4 Global CAR T-Cell Therapy Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Allogeneic (2021-2026)
6.5.2 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Autologous (2021-2026)
7 Global CAR T-Cell Therapy Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global CAR T-Cell Therapy Historical Sales Volume by End User (2021-2026)
7.3 Global CAR T-Cell Therapy Historical Revenue by End User (2021-2026)
7.4 Global CAR T-Cell Therapy Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Cancer Research Centers (2021-2026)
7.5.3 Global CAR T-Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)
8 Leading Companies Profiles
8.1 Cellectis (France)
8.1.1 Cellectis (France) Corporation Information
8.1.2 Cellectis (France) - CAR T-Cell Therapy Product Portfolio and Specification
8.1.3 Cellectis (France) Performance Analysis (2021-2026)
8.1.4 Cellectis (France) Business and Markets Served
8.1.5 Cellectis (France) Recent Developments
8.2 CARsgen Therapeutics (China)
8.2.1 CARsgen Therapeutics (China) Corporation Information
8.2.2 CARsgen Therapeutics (China) - CAR T-Cell Therapy Product Portfolio and Specification
8.2.3 CARsgen Therapeutics (China) Performance Analysis (2021-2026)
8.2.4 CARsgen Therapeutics (China) Business and Markets Served
8.2.5 CARsgen Therapeutics (China) Recent Developments
8.3 Autolus Therapeutics PLC (UK)
8.3.1 Autolus Therapeutics PLC (UK) Corporation Information
8.3.2 Autolus Therapeutics PLC (UK) - CAR T-Cell Therapy Product Portfolio and Specification
8.3.3 Autolus Therapeutics PLC (UK) Performance Analysis (2021-2026)
8.3.4 Autolus Therapeutics PLC (UK) Business and Markets Served
8.3.5 Autolus Therapeutics PLC (UK) Recent Developments
8.4 Sorrento Therapeutics (US)
8.4.1 Sorrento Therapeutics (US) Corporation Information
8.4.2 Sorrento Therapeutics (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.4.3 Sorrento Therapeutics (US) Performance Analysis (2021-2026)
8.4.4 Sorrento Therapeutics (US) Business and Markets Served
8.4.5 Sorrento Therapeutics (US) Recent Developments
8.5 Mustang Bio (US)
8.5.1 Mustang Bio (US) Corporation Information
8.5.2 Mustang Bio (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.5.3 Mustang Bio (US) Performance Analysis (2021-2026)
8.5.4 Mustang Bio (US) Business and Markets Served
8.5.5 Mustang Bio (US) Recent Developments
8.6 Novartis AG (Switzerland)
8.6.1 Novartis AG (Switzerland) Corporation Information
8.6.2 Novartis AG (Switzerland) - CAR T-Cell Therapy Product Portfolio and Specification
8.6.3 Novartis AG (Switzerland) Performance Analysis (2021-2026)
8.6.4 Novartis AG (Switzerland) Business and Markets Served
8.6.5 Novartis AG (Switzerland) Recent Developments
8.7 Kite Pharma (US)
8.7.1 Kite Pharma (US) Corporation Information
8.7.2 Kite Pharma (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.7.3 Kite Pharma (US) Performance Analysis (2021-2026)
8.7.4 Kite Pharma (US) Business and Markets Served
8.7.5 Kite Pharma (US) Recent Developments
8.8 Legend Biotech (US)
8.8.1 Legend Biotech (US) Corporation Information
8.8.2 Legend Biotech (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.8.3 Legend Biotech (US) Performance Analysis (2021-2026)
8.8.4 Legend Biotech (US) Business and Markets Served
8.8.5 Legend Biotech (US) Recent Developments
8.9 Juno Therapeutics (US)
8.9.1 Juno Therapeutics (US) Corporation Information
8.9.2 Juno Therapeutics (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.9.3 Juno Therapeutics (US) Performance Analysis (2021-2026)
8.9.4 Juno Therapeutics (US) Business and Markets Served
8.9.5 Juno Therapeutics (US) Recent Developments
8.10 Pfizer, Inc. (US)
8.10.1 Pfizer, Inc. (US) Corporation Information
8.10.2 Pfizer, Inc. (US) - CAR T-Cell Therapy Product Portfolio and Specification
8.10.3 Pfizer, Inc. (US) Performance Analysis (2021-2026)
8.10.4 Pfizer, Inc. (US) Business and Markets Served
8.10.5 Pfizer, Inc. (US) Recent Developments
9 Global CAR T-Cell Therapy Market Forecast by Product Type and End User (2026-2034)
9.1 Global CAR T-Cell Therapy Market Forecast by Product Type (2026-2034)
9.1.1 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Allogeneic (2026-2034)
9.1.2 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Autologous (2026-2034)
9.2 Global CAR T-Cell Therapy Market Forecast by End User (2026-2034)
9.2.1 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Cancer Research Centers (2026-2034)
9.2.3 Global CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
10 Global CAR T-Cell Therapy Market Forecast by Geographic Region (2026-2034)
10.1 Global CAR T-Cell Therapy Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa CAR T-Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer